Clinical trial efforts in Alzheimer disease: why test statins?

Neurology. 2010 Mar 23;74(12):945-6. doi: 10.1212/WNL.0b013e3181d6479a. Epub 2010 Mar 3.
No abstract available

Publication types

  • Editorial
  • Research Support, N.I.H., Extramural
  • Comment

MeSH terms

  • Alzheimer Disease / drug therapy*
  • Alzheimer Disease / etiology*
  • Atorvastatin
  • Heptanoic Acids / therapeutic use*
  • Humans
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / metabolism
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors / therapeutic use
  • Hypercholesterolemia / complications*
  • Hypercholesterolemia / diagnosis
  • Hypercholesterolemia / metabolism
  • Pyrroles / therapeutic use*
  • Randomized Controlled Trials as Topic

Substances

  • Heptanoic Acids
  • Hydroxymethylglutaryl-CoA Reductase Inhibitors
  • Pyrroles
  • Atorvastatin